Free tool
Heavily traded stocks
We cover 40 companies whose typical session turns over more than $10.00M. The median market value in the group is $12.87B. Across the group, the median move over the past trading day is +0.10%. 74% of the 39 with a 200-day average trade above it. Price change over the past year runs from −14.9% to +127.7% across the middle 80 percent of the group, with a median of +29.7%.
Other lists in this group
Table
40 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% | Oct 14, 2026 |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% | Oct 20, 2026 |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% | Oct 20, 2026 |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% | Oct 23, 2026 |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% | Oct 21, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% | Oct 27, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% | Oct 22, 2026 |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% | Oct 27, 2026 |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% | Oct 19, 2026 |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% | Sep 9, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% | Oct 21, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% | Oct 26, 2026 |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% | Oct 19, 2026 |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% | Oct 21, 2026 |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% | Oct 26, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% | Oct 22, 2026 |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% | Sep 21, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% | Oct 27, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% | Oct 27, 2026 |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% | Oct 27, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.